ASND logo

Ascendis Pharma A/S (ASND) Depreciation and amortization

annual D&A:

$19.17M-$1.30M(-6.35%)
December 31, 2024

Summary

  • As of today (May 31, 2025), ASND annual depreciation & amortization is $19.17 million, with the most recent change of -$1.30 million (-6.35%) on December 31, 2024.
  • During the last 3 years, ASND annual D&A has risen by +$962.40 thousand (+5.28%).
  • ASND annual D&A is now -6.35% below its all-time high of $20.47 million, reached on December 31, 2023.

Performance

ASND Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDincome statement metrics

quarterly D&A:

N/A
March 31, 2025

Summary

  • ASND quarterly depreciation & amortization is not available.

Performance

ASND quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherASNDincome statement metrics

TTM D&A:

N/A
March 31, 2025

Summary

  • ASND TTM depreciation & amortization is not available.

Performance

ASND TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherASNDincome statement metrics

ASND Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.3%--
3 y3 years+5.3%--
5 y5 years+156.0%--

ASND Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.3%+5.3%
5 y5-year-6.3%+156.0%
alltimeall time-6.3%+3464.4%

ASND Depreciation and amortization History

DateAnnualQuarterlyTTM
Dec 2024
$19.17M(-6.4%)
$4.61M(-8.0%)
$19.17M(-3.5%)
Sep 2024
-
$5.01M(+7.1%)
$19.86M(-0.7%)
Jun 2024
-
$4.68M(-3.7%)
$20.00M(-2.2%)
Mar 2024
-
$4.86M(-8.3%)
$20.45M(-0.1%)
Dec 2023
$20.47M(+8.1%)
$5.30M(+3.0%)
$20.47M(-1.0%)
Sep 2023
-
$5.15M(+0.2%)
$20.69M(+5.7%)
Jun 2023
-
$5.14M(+5.3%)
$19.58M(+3.8%)
Mar 2023
-
$4.88M(-11.5%)
$18.87M(-0.4%)
Dec 2022
$18.94M(+4.0%)
$5.52M(+36.6%)
$18.94M(+2.2%)
Sep 2022
-
$4.04M(-8.7%)
$18.52M(-1.2%)
Jun 2022
-
$4.43M(-10.7%)
$18.75M(+0.3%)
Mar 2022
-
$4.95M(-2.9%)
$18.69M(+2.6%)
Dec 2021
$18.21M(+68.8%)
$5.10M(+19.5%)
$18.21M(+11.4%)
Sep 2021
-
$4.27M(-2.2%)
$16.34M(+8.9%)
Jun 2021
-
$4.36M(-2.5%)
$15.01M(+14.9%)
Mar 2021
-
$4.48M(+38.4%)
$13.07M(+21.1%)
Dec 2020
$10.79M(+44.1%)
$3.23M(+10.0%)
$10.79M(+10.1%)
Sep 2020
-
$2.94M(+21.6%)
$9.80M(+9.4%)
Jun 2020
-
$2.42M(+9.9%)
$8.96M(+9.1%)
Mar 2020
-
$2.20M(-2.0%)
$8.22M(+9.7%)
Dec 2019
$7.49M
$2.24M(+7.0%)
$7.49M(+34.9%)
Sep 2019
-
$2.10M(+25.4%)
$5.55M(+49.5%)
Jun 2019
-
$1.67M(+13.7%)
$3.71M(+63.6%)
DateAnnualQuarterlyTTM
Mar 2019
-
$1.47M(+382.1%)
$2.27M(+118.3%)
Dec 2018
$1.04M(+25.0%)
$305.40K(+17.6%)
$1.04M(+11.3%)
Sep 2018
-
$259.70K(+12.5%)
$933.60K(+1.3%)
Jun 2018
-
$230.80K(-5.1%)
$921.20K(+3.0%)
Mar 2018
-
$243.20K(+21.7%)
$894.40K(+7.6%)
Dec 2017
$831.30K(+10.9%)
$199.90K(-19.2%)
$831.20K(+1.6%)
Sep 2017
-
$247.30K(+21.2%)
$818.10K(+8.4%)
Jun 2017
-
$204.00K(+13.3%)
$754.90K(+0.6%)
Mar 2017
-
$180.00K(-3.6%)
$750.70K(+0.2%)
Dec 2016
$749.30K(+21.0%)
$186.80K(+1.5%)
$749.40K(+2.4%)
Sep 2016
-
$184.10K(-7.9%)
$731.70K(+3.0%)
Jun 2016
-
$199.80K(+11.8%)
$710.40K(+7.8%)
Mar 2016
-
$178.70K(+5.7%)
$659.10K(+6.4%)
Dec 2015
$619.20K(-7.6%)
$169.10K(+3.9%)
$619.20K(-1.9%)
Sep 2015
-
$162.80K(+9.6%)
$631.30K(+1.6%)
Jun 2015
-
$148.50K(+7.0%)
$621.50K(-3.8%)
Mar 2015
-
$138.80K(-23.4%)
$646.00K(-3.6%)
Dec 2014
$670.20K(+24.6%)
$181.20K(+18.4%)
$670.20K(+37.1%)
Sep 2014
-
$153.00K(-11.6%)
$489.00K(+45.5%)
Jun 2014
-
$173.00K(+6.1%)
$336.00K(+106.1%)
Mar 2014
-
$163.00K
$163.00K
Dec 2013
$537.90K(-1.6%)
-
-
Dec 2012
$546.40K
-
-

FAQ

  • What is Ascendis Pharma A/S annual depreciation & amortization?
  • What is the all time high annual D&A for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual D&A year-on-year change?
  • What is the all time high quarterly D&A for Ascendis Pharma A/S?
  • What is the all time high TTM D&A for Ascendis Pharma A/S?

What is Ascendis Pharma A/S annual depreciation & amortization?

The current annual D&A of ASND is $19.17M

What is the all time high annual D&A for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual depreciation & amortization is $20.47M

What is Ascendis Pharma A/S annual D&A year-on-year change?

Over the past year, ASND annual depreciation & amortization has changed by -$1.30M (-6.35%)

What is the all time high quarterly D&A for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly depreciation & amortization is $5.52M

What is the all time high TTM D&A for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM depreciation & amortization is $20.69M
On this page